Stopcrome 2ml Injection

Introduction

Stopcrome is a medication that contains the active ingredient Carbazochrome. It is available in the form of an injection and is commonly prescribed by healthcare professionals.

Uses

Stopcrome is primarily used to treat bleeding disorders. It is often prescribed for conditions such as postoperative bleeding, gastrointestinal bleeding, and bleeding associated with dental procedures. It helps to control bleeding by promoting blood clotting and reducing the duration of bleeding.

Dosage and Administration

The dosage of Stopcrome may vary depending on the severity of the bleeding disorder and the patient’s individual response. Follow the instructions provided by your healthcare professional. The injection is typically administered by a healthcare professional, either intravenously or intramuscularly.

Mechanism of Action

Carbazochrome, the active ingredient in Stopcrome, works by strengthening the capillary walls and enhancing platelet function. This helps to promote blood clotting and reduce bleeding. It also has anti-inflammatory properties that can help reduce swelling and inflammation in the affected area.

Side Effects

Common side effects may include mild pain or discomfort at the injection site, dizziness, and gastrointestinal disturbances such as nausea or vomiting. These side effects are generally temporary and should resolve on their own.

However, if you experience any serious side effects such as severe allergic reactions, difficulty breathing, or chest pain, seek immediate medical attention.

Drug Interactions

inform your healthcare professional about all the medications you are currently taking, including over-the-counter drugs, herbal supplements, and vitamins. Stopcrome may interact with certain medications, such as anticoagulants (blood thinners) or antiplatelet drugs, increasing the risk of bleeding. Your healthcare professional will consider these potential interactions and adjust your treatment plan accordingly.

Precautions

Before using Stopcrome, inform your healthcare professional about any known allergies or sensitivities to medications. Additionally, let your healthcare professional know if you have any pre-existing medical conditions, such as liver or kidney problems, as it may affect the dosage or use of this medication.

Stopcrome is contraindicated in patients with a history of hypersensitivity to Carbazochrome or any of the other ingredients in the formulation.

Storage

Stopcrome should be stored at the recommended temperature and away from direct sunlight and heat sources. Follow the storage instructions provided by your healthcare professional or the product packaging. Always keep this medication out of reach of children and pets.

Patient Tips

• Follow the dosage instructions provided by your healthcare professional and do not exceed the recommended dose.
• If you miss a dose, contact your healthcare professional for guidance on the next steps.
• Inform your healthcare professional about any other medications you are taking to avoid potential drug interactions.
• If you experience any unexpected or severe side effects, seek immediate medical attention.
• Keep all appointments with your healthcare professional for monitoring of your condition and adjustment of your treatment plan if necessary.
• Store the medication properly as instructed to maintain its effectiveness.
• If you have any questions or concerns about Stopcrome, don’t hesitate to reach out to your healthcare professional for clarification. They are there to support and guide you throughout your treatment journey.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Carbazochrome (International database) (Drugs.com) [Accessed 15 Jun. 2024] (online) Available at:
• Sayiner HS, Kandemirli F, Dalgic SS, Monajjemi M, Mollaamin F. Carbazochrome carbon nanotube as drug delivery nanocarrier for anti-bleeding drug: quantum chemical study. J Mol Model. 2021 Dec 20;28(1):11. doi: 10.1007/s00894-021-04948-1. [Accessed 15 Jun. 2024] Available at:
• Takahashi K, Sasaki T, Ueno N, Uehara K, Kobayashi Y, Sugiyama Y, Murakami Y, Kunogi T, Ando K, Kashima S, Moriichi K, Tanabe H, Okumura T, Fujiya M. Carbazochrome sodium sulfonate is not effective for prevention of post-gastric endoscopic submucosal dissection bleeding: A retrospective study. Surg Endosc. 2022 Oct;36(10):7486-7493. doi: 10.1007/s00464-022-09171-4. Epub 2022 Mar 7. [Accessed 14 Jun. 2024] Available at:
• Adrenochrome (International database) (Drugs.com) [Accessed 10 Jun. 2024] (online) Available at: